Novavax | NVAX - Ebit


Novavax reported $20.94M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Adma Biologics USD 59.23M 3.52M Mar/2026
Agenus USD 15.05M 656K Mar/2026
AstraZeneca USD 3.16B 3.95B Jun/2026
BioCryst Pharmaceuticals USD 98.46M 161.92M Jun/2026
Cassava Sciences USD -11.17M 2.38M Mar/2026
Geron USD -236K 10.55M Mar/2026
GlaxoSmithKline GBP 2.6B 312M Jun/2026
MannKind USD -68.23M 8.76M Jun/2026
Merck USD 840M 2.72B Jun/2026
Minerva Neurosciences USD -4.37M 1.71M Sep/2024
Moderna USD -815M 573M Jun/2026
Novartis USD 4.18B 118M Mar/2026
Novavax USD 20.94M 100.32M Dec/2025
Pfizer USD -180M 5.16B Jun/2026
Sanofi EUR 1.12B 811M Jun/2026
Sarepta Therapeutics USD 13.29M 345.14M Jun/2026
TG Therapeutics USD 21.67M 13.12M Jun/2026